blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3807320

EP3807320 - COMBINATION THERAPY WITH NEOANTIGEN VACCINE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  18.08.2023
Database last updated on 16.09.2024
FormerRequest for examination was made
Status updated on  19.03.2021
FormerThe international publication has been made
Status updated on  21.12.2019
Most recent event   Tooltip19.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
BioNTech US Inc.
40 Erie Street, Suite 110
Cambridge, MA 02139 / US
[2021/16]
Inventor(s)01 / ANG, Robert
34 Larchmont Avenue
Waban, Massachusetts 02468 / US
02 / GAYNOR, Richard
135 Clarendon Street, Apt. 8W
Boston, Massachusetts 02116 / US
03 / GOLDSTEIN, Matthew
30 Billings Lane
Jamaica Plain, Massachusetts 02130 / US
 [2021/26]
Former [2021/16]01 / ANG, Robert
34 Larchmont Avenue
Waban, Massachusetts 02468 / US
02 / GAYNOR, Richard
135 Clarendon Street, Apt. 8W
Boston, Massachusetts 02116 / US
03 / GOLDSTEIN, Matthew
780 Centre Street, Unit 2
Jamaica Plain, Massachusetts 02130 / US
Representative(s)Brand Murray Fuller LLP
50 Eastcastle Street
London W1W 8EA / GB
[2021/16]
Application number, filing date19820230.111.06.2019
[2021/16]
WO2019US36632
Priority number, dateUS201862684013P12.06.2018         Original published format: US 201862684013 P
[2021/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2019241306
Date:19.12.2019
Language:EN
[2019/51]
Type: A2 Application without search report 
No.:EP3807320
Date:21.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 19.12.2019 takes the place of the publication of the European patent application.
[2021/16]
Search report(s)International search report - published on:US23.01.2020
(Supplementary) European search report - dispatched on:EP22.02.2022
ClassificationIPC:C07K16/28, A61K39/395, A61P35/00, A61K39/00, A61K35/17
[2022/12]
CPC:
A61K45/06 (EP); A61K39/3955 (EP,US); A61K39/0011 (EP,US);
A61K39/39 (US); A61P35/00 (EP,US); C07K16/2818 (EP);
A61K2039/507 (EP); A61K2039/5154 (EP,US); A61K2039/5158 (EP,US);
A61K2039/545 (US); A61K2039/55 (US); A61K2039/55561 (EP);
A61K2039/55583 (US); A61K2039/70 (EP); A61K2039/876 (EP);
A61K35/17 (EP,US); C07K2317/21 (EP); C07K2317/76 (EP) (-)
C-Set:
A61K39/0011, A61K2300/00 (EP);
A61K39/3955, A61K2300/00 (EP)
Former IPC [2021/16]C07K16/28, A61K39/395, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/16]
TitleGerman:KOMBINATIONSTHERAPIE MIT NEOANTIGEN-IMPFSTOFF[2021/16]
English:COMBINATION THERAPY WITH NEOANTIGEN VACCINE[2021/16]
French:POLYTHÉRAPIE COMPRENANT UN VACCIN À BASE DE NÉOANTIGÈNES[2021/16]
Entry into regional phase05.01.2021National basic fee paid 
05.01.2021Search fee paid 
05.01.2021Designation fee(s) paid 
05.01.2021Examination fee paid 
Examination procedure05.01.2021Examination requested  [2021/16]
18.10.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
30.11.2022Amendment by applicant (claims and/or description)
21.08.2023Despatch of a communication from the examining division (Time limit: M06)
21.02.2024Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
30.11.2022Request for further processing filed
30.11.2022Full payment received (date of receipt of payment)
Request granted
08.12.2022Decision despatched
Fees paidRenewal fee
05.01.2021Renewal fee patent year 03
27.06.2022Renewal fee patent year 04
20.06.2023Renewal fee patent year 05
19.06.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO2015095811  (BOARD INST INC [US], et al);
International search[Y]US2012301488  (ZHANG YONGKE [US], et al);
 [XY]WO2016023960  (ALLIGATOR BIOSCIENCE AB [SE]);
 [Y]US2016069895  (DELAMARRE LELIA [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.